Tumor necrosis factor α in aGVHD patients contributed to the impairment of recipient bone marrow MSC stemness and deficiency of their hematopoiesis-promotion capacity

Abstract Background Though accumulated evidence has demonstrated visceral organ involvement in acute graft-versus-host disease (aGVHD), how aGVHD influences the bone marrow (BM) niche and the reconstitution of hematopoiesis post-hematopoietic stem cell transplantation remains largely unknown. Method...

Full description

Bibliographic Details
Main Authors: Li Ding, Hong-Mei Ning, Pei-Lin Li, Hong-Min Yan, Dong-Mei Han, Xiao-Li Zheng, Jing Liu, Ling Zhu, Mei Xue, Ning Mao, Zi-Kuan Guo, Heng Zhu, Heng-Xiang Wang
Format: Article
Language:English
Published: BMC 2020-03-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13287-020-01615-9
id doaj-c5470ee69297455481370ff33fd4819b
record_format Article
spelling doaj-c5470ee69297455481370ff33fd4819b2020-11-25T02:30:46ZengBMCStem Cell Research & Therapy1757-65122020-03-0111111410.1186/s13287-020-01615-9Tumor necrosis factor α in aGVHD patients contributed to the impairment of recipient bone marrow MSC stemness and deficiency of their hematopoiesis-promotion capacityLi Ding0Hong-Mei Ning1Pei-Lin Li2Hong-Min Yan3Dong-Mei Han4Xiao-Li Zheng5Jing Liu6Ling Zhu7Mei Xue8Ning Mao9Zi-Kuan Guo10Heng Zhu11Heng-Xiang Wang12Medical Center of Air ForcesThe Fifth Medical Center of Chinese PLA General HospitalBeijing Institute of Radiation MedicineMedical Center of Air ForcesMedical Center of Air ForcesMedical Center of Air ForcesMedical Center of Air ForcesMedical Center of Air ForcesMedical Center of Air ForcesBeijing Institute of Basic Medical SciencesBeijing Institute of Radiation MedicineBeijing Institute of Radiation MedicineMedical Center of Air ForcesAbstract Background Though accumulated evidence has demonstrated visceral organ involvement in acute graft-versus-host disease (aGVHD), how aGVHD influences the bone marrow (BM) niche and the reconstitution of hematopoiesis post-hematopoietic stem cell transplantation remains largely unknown. Methods In the current study, the cell morphology, immunophenotype, multi-differentiation capacity, self-renewal capacity, and hematopoiesis promotion of the MSCs from aGVHD and non-aGVHD patients were investigated. Additionally, the stemness and hematopoiesis-promoting property of healthy donor-derived MSCs were evaluated in the presence of BM supernatant from aGVHD patients. Mechanistically, antibodies targeting inflammatory cytokines involved in aGVHD were added into the MSC culture. Furthermore, a recombinant human tumor necrosis factor (TNF-α) receptor-Ig fusion protein (rhTNFR:Fc) was used to protect healthy donor-derived MSCs. Moreover, mRNA sequencing was performed to explore the underlying mechanisms. Results The aGVHD MSCs exhibited morphological and immunophenotypic characteristics that were similar to those of the non-aGVHD MSCs. However, the osteogenic and adipogenic activities of the aGVHD MSCs significantly decreased. Additionally, the colony formation capacity and the expression of self-renewal-related genes remarkably decreased in aGVHD MSCs. Further, the hematopoiesis-supporting capacity of aGVHD MSCs significantly reduced. The antibody neutralization results showed that TNF-α contributed to the impairment of MSC properties. Moreover, rhTNFR:Fc exhibited notable protective effects on MSCs in the aGVHD BM supernatants. The mRNA sequencing results indicated that the TNF-α pathway and the Toll-like receptor pathway may be activated by TNF-α. Conclusions Thus, our data demonstrate MSCs as cellular targets of aGVHD and suggest a potential role of TNF-α blockage in maintaining the BM niche of aGVHD patients.http://link.springer.com/article/10.1186/s13287-020-01615-9Acute graft versus host diseaseBone marrow nicheMesenchymal stem cellStemnessTumor necrosis factor-α
collection DOAJ
language English
format Article
sources DOAJ
author Li Ding
Hong-Mei Ning
Pei-Lin Li
Hong-Min Yan
Dong-Mei Han
Xiao-Li Zheng
Jing Liu
Ling Zhu
Mei Xue
Ning Mao
Zi-Kuan Guo
Heng Zhu
Heng-Xiang Wang
spellingShingle Li Ding
Hong-Mei Ning
Pei-Lin Li
Hong-Min Yan
Dong-Mei Han
Xiao-Li Zheng
Jing Liu
Ling Zhu
Mei Xue
Ning Mao
Zi-Kuan Guo
Heng Zhu
Heng-Xiang Wang
Tumor necrosis factor α in aGVHD patients contributed to the impairment of recipient bone marrow MSC stemness and deficiency of their hematopoiesis-promotion capacity
Stem Cell Research & Therapy
Acute graft versus host disease
Bone marrow niche
Mesenchymal stem cell
Stemness
Tumor necrosis factor-α
author_facet Li Ding
Hong-Mei Ning
Pei-Lin Li
Hong-Min Yan
Dong-Mei Han
Xiao-Li Zheng
Jing Liu
Ling Zhu
Mei Xue
Ning Mao
Zi-Kuan Guo
Heng Zhu
Heng-Xiang Wang
author_sort Li Ding
title Tumor necrosis factor α in aGVHD patients contributed to the impairment of recipient bone marrow MSC stemness and deficiency of their hematopoiesis-promotion capacity
title_short Tumor necrosis factor α in aGVHD patients contributed to the impairment of recipient bone marrow MSC stemness and deficiency of their hematopoiesis-promotion capacity
title_full Tumor necrosis factor α in aGVHD patients contributed to the impairment of recipient bone marrow MSC stemness and deficiency of their hematopoiesis-promotion capacity
title_fullStr Tumor necrosis factor α in aGVHD patients contributed to the impairment of recipient bone marrow MSC stemness and deficiency of their hematopoiesis-promotion capacity
title_full_unstemmed Tumor necrosis factor α in aGVHD patients contributed to the impairment of recipient bone marrow MSC stemness and deficiency of their hematopoiesis-promotion capacity
title_sort tumor necrosis factor α in agvhd patients contributed to the impairment of recipient bone marrow msc stemness and deficiency of their hematopoiesis-promotion capacity
publisher BMC
series Stem Cell Research & Therapy
issn 1757-6512
publishDate 2020-03-01
description Abstract Background Though accumulated evidence has demonstrated visceral organ involvement in acute graft-versus-host disease (aGVHD), how aGVHD influences the bone marrow (BM) niche and the reconstitution of hematopoiesis post-hematopoietic stem cell transplantation remains largely unknown. Methods In the current study, the cell morphology, immunophenotype, multi-differentiation capacity, self-renewal capacity, and hematopoiesis promotion of the MSCs from aGVHD and non-aGVHD patients were investigated. Additionally, the stemness and hematopoiesis-promoting property of healthy donor-derived MSCs were evaluated in the presence of BM supernatant from aGVHD patients. Mechanistically, antibodies targeting inflammatory cytokines involved in aGVHD were added into the MSC culture. Furthermore, a recombinant human tumor necrosis factor (TNF-α) receptor-Ig fusion protein (rhTNFR:Fc) was used to protect healthy donor-derived MSCs. Moreover, mRNA sequencing was performed to explore the underlying mechanisms. Results The aGVHD MSCs exhibited morphological and immunophenotypic characteristics that were similar to those of the non-aGVHD MSCs. However, the osteogenic and adipogenic activities of the aGVHD MSCs significantly decreased. Additionally, the colony formation capacity and the expression of self-renewal-related genes remarkably decreased in aGVHD MSCs. Further, the hematopoiesis-supporting capacity of aGVHD MSCs significantly reduced. The antibody neutralization results showed that TNF-α contributed to the impairment of MSC properties. Moreover, rhTNFR:Fc exhibited notable protective effects on MSCs in the aGVHD BM supernatants. The mRNA sequencing results indicated that the TNF-α pathway and the Toll-like receptor pathway may be activated by TNF-α. Conclusions Thus, our data demonstrate MSCs as cellular targets of aGVHD and suggest a potential role of TNF-α blockage in maintaining the BM niche of aGVHD patients.
topic Acute graft versus host disease
Bone marrow niche
Mesenchymal stem cell
Stemness
Tumor necrosis factor-α
url http://link.springer.com/article/10.1186/s13287-020-01615-9
work_keys_str_mv AT liding tumornecrosisfactorainagvhdpatientscontributedtotheimpairmentofrecipientbonemarrowmscstemnessanddeficiencyoftheirhematopoiesispromotioncapacity
AT hongmeining tumornecrosisfactorainagvhdpatientscontributedtotheimpairmentofrecipientbonemarrowmscstemnessanddeficiencyoftheirhematopoiesispromotioncapacity
AT peilinli tumornecrosisfactorainagvhdpatientscontributedtotheimpairmentofrecipientbonemarrowmscstemnessanddeficiencyoftheirhematopoiesispromotioncapacity
AT hongminyan tumornecrosisfactorainagvhdpatientscontributedtotheimpairmentofrecipientbonemarrowmscstemnessanddeficiencyoftheirhematopoiesispromotioncapacity
AT dongmeihan tumornecrosisfactorainagvhdpatientscontributedtotheimpairmentofrecipientbonemarrowmscstemnessanddeficiencyoftheirhematopoiesispromotioncapacity
AT xiaolizheng tumornecrosisfactorainagvhdpatientscontributedtotheimpairmentofrecipientbonemarrowmscstemnessanddeficiencyoftheirhematopoiesispromotioncapacity
AT jingliu tumornecrosisfactorainagvhdpatientscontributedtotheimpairmentofrecipientbonemarrowmscstemnessanddeficiencyoftheirhematopoiesispromotioncapacity
AT lingzhu tumornecrosisfactorainagvhdpatientscontributedtotheimpairmentofrecipientbonemarrowmscstemnessanddeficiencyoftheirhematopoiesispromotioncapacity
AT meixue tumornecrosisfactorainagvhdpatientscontributedtotheimpairmentofrecipientbonemarrowmscstemnessanddeficiencyoftheirhematopoiesispromotioncapacity
AT ningmao tumornecrosisfactorainagvhdpatientscontributedtotheimpairmentofrecipientbonemarrowmscstemnessanddeficiencyoftheirhematopoiesispromotioncapacity
AT zikuanguo tumornecrosisfactorainagvhdpatientscontributedtotheimpairmentofrecipientbonemarrowmscstemnessanddeficiencyoftheirhematopoiesispromotioncapacity
AT hengzhu tumornecrosisfactorainagvhdpatientscontributedtotheimpairmentofrecipientbonemarrowmscstemnessanddeficiencyoftheirhematopoiesispromotioncapacity
AT hengxiangwang tumornecrosisfactorainagvhdpatientscontributedtotheimpairmentofrecipientbonemarrowmscstemnessanddeficiencyoftheirhematopoiesispromotioncapacity
_version_ 1724828081132142592